Ensayo clínico

Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)

NCT: NCT03554356 · ACTIVE_NOT_RECRUITING

ID NCTNCT03554356

EstadoACTIVE_NOT_RECRUITING

Fecha de inicio2018-09-04

SponsorUniversity of North Carolina, Chapel Hill (OTHER)

First posted2018-06-13

Last updated2026-09-14

Resumen breve

A multicenter, prospective, single arm, non randomized clinical trial to evaluate the safety and efficacy of the C2 CryoBalloon Focal Ablation System (CbFAS) for the treatment of persistent dysplasia or intestinal metaplasia (IM) in the tubular esophagus after 3 or more radiofrequency ablations (RFA) for dysplastic BE, or \<50% eradication of Barrett's Esophagus (BE) after 2 RFA treatments.

Fuente oficial

Ver en ClinicalTrials.gov →

Datos obtenidos de la API de ClinicalTrials.gov. Para conocer el estado más reciente, consulte el registro oficial.